Ceptaris Therapeutics, Inc has raised $10 million through a Series D-1 private placement of preferred stock.
Burrill & Company
Breaking News
- Joe Biden Bashes Donald Trump for Inheriting His Wealth as He Touts His Middle-Class Upbringing in Union Speech
- ASML's Potential Exit from the Netherlands: Dutch Minister Remains Optimistic About Company's Future
- Shipping Industry Calls on UN to Protect Vessels, Seafarers Following Iran's Seizure of MSC Aries Container Ship
Subscribe to VCpost newsletter
Most Popular
- SSDI Payment April 2024: Who Will Receive Social Security Benefits Today?
- Tesla Spends $200,000 in Promoting Elon Musk's Social Media Platform X Following Mention of 'Minimal Advertising Efforts'
- Australian Farmer Prepares Grave of 3,000 Sheep After Failing to Find Buyer
- Where's My Child Tax Credit 2024: When to Receive My Money After April 15 Tax Filing Deadline?
- Brazilian Woman Wheels Her Dead Uncle Into the Bank to Withdraw Loan in His Name
- Elon Musk's SpaceX Working With Northrop Grumman on Secret Spy Satellite Project for US Intelligence: Report
- Michigan Family Sues Wendy's for $20 Million After 11-Year-Old Girl Suffered Deadly E.Coli Infection
- Innocent Female Uber Driver, 61, Shot Dead by 81-Year-Old Ohio Man Who Was Targeted by Scammers
